Viewing Study NCT02168803


Ignite Creation Date: 2025-12-24 @ 7:47 PM
Ignite Modification Date: 2026-01-04 @ 1:58 PM
Study NCT ID: NCT02168803
Status: COMPLETED
Last Update Posted: 2018-10-03
First Post: 2014-05-22
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Evacetrapib in Participants With Abnormal Cholesterol
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dyslipidemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None abnormal cholesterol View